ArcheMedX Promotes Kelly Ritch to Executive Vice President of Product and Clinical Research Solutions
Charlottesville, VA — July 14, 2020
ArcheMedX leadership is pleased to announce the promotion of Kelly Ritch to EVP of Product and Clinical Research Solutions. Ritch joined in 2019 to support the increasing demand for Ready, the company’s clinical trials platform, with sponsors and CROs.
“Kelly has already made an indelible impact on our team in the time she’s been at ArcheMedX, and we are thrilled to elevate her into a senior leadership role. She continues to demonstrate the mindset and elite leadership skills that we require in order to scale,” said Joel Selzer, CEO and co-founder.
Ritch is known as a dynamic and innovative executive adept at driving high-performance and long-term value through the applied use of software, data, and technology driven solutions for clinical research. Her operational expertise and strategic mindset has already enabled ArcheMedX to scale the capabilities it provides to multiple clients in the clinical operations space.
“It’s been an incredible experience working closely with clinical operations leaders so far to harness the predictive power ArcheMedX provides,” said Ritch. “I’ve seen first-hand the impact that more informed decisions and improved performance can have on clinical trial efficiency and outcomes.”
Nearly every clinical trial encounters operational challenges and according to industry reports an estimated 85% of all clinical trials will experience delays, with 94% being delayed by over a month. These delays can have significant financial costs for each day that a trial impedes a product’s development and launch.
With her promotion, Ms. Ritch will expand her oversight across product strategy and clinical research market development, as well as contribute more to the company’s thought leadership.
Before joining the ArcheMedX team, Ms. Ritch led clinical data management, sales and marketing, clinical trial operations, and strategic partnerships for 20+ years with both sponsors and CROs. While creating and leading high-performance teams across clinical research functions, Ritch has had the opportunity to evaluate, implement, and develop a number of key software platforms used to support and improve clinical trial performance. Ms. Ritch has earned degrees from University of Virginia, University of North Carolina Chapel Hill, and University of Virginia Darden School of Business.
ArcheMedX helps companies across the life sciences and healthcare industries to better equip, evaluate, and predict team and clinician performance, in order to accelerate the development and adoption of new clinical treatments and best practices.
ArcheMedX’s flagship product, Ready, predicts and improves how teams and clinicians will apply knowledge and skills in real-world scenarios. Ready uses behavioral science to enhance how individuals learn and retain information, and delivers actionable insights enabling leaders to identify high performers, potential risks, and areas for improvement.
To learn more about our readiness solutions across clinical operations, commercial, and medical education, visit www.archemedx.com or follow ArcheMedX on LinkedIn.